Asthma Research Study

Study to evaluate the efficacy of varying doses of study drug; CHF 718 beclomethasone dipropionate pressurized metered dose inhaler (pMDI), compared to QVAR & placebo; in the management of uncontrolled or poorly controlled, moderate asthma patients.

The study will last approximately 12 weeks for each subject and a total of 5 clinic visits will be performed during the study.

After a 2-week run-in period, subjects will enter the 8-week treatment period. Subjects will be randomized to 1 of 5 treatments, in a double-blind fashion (study subject & study doctor are blinded to the treatment assigned). Treatments assigned are 3 varying doses of the study drug, beclomethaone dipropionate

Canadian Pharmacy, canadian rx online pharmacy support team viagra reliable non prescription online pharmacy, propecia canada pharmacy The Generic Pharmacy Philippines

pMDI, compared to QVAR and placebo.